← Leaderboards
Reuben S Harris
University Of Texas Hlth Science Center
$27,469,226
Attributed
$29,118,050
Total exposure
20
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $80M · FY2005–25$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$116,857,571 · 23
By mechanism
U19$77,273,607 · 3
P01$26,952,596 · 10
R01$6,994,611 · 4
R37$4,222,873 · 1
R21$811,549 · 2
R56$524,212 · 1
Top collaborators
- Douglas Yee9 shared
- Hideki Aihara6 shared
- Fang Li2 shared
- Sarat Chandarlapaty1 shared
- Jorge Reis-Filho1 shared
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsMolecularCellsBaseMediatingProgramsMutationDeaminationEnzymesCytosineComplexUracilInhibitor/AntagonistMutagenesisHiv-1ReportingInnovationLeadVirusGenomicsDeaminaseImmuneEventViral
Grant awards (85)
APOBEC Mutagenesis in Cancer$2,002,938
P01 · FY2025 · CA · contact PI
PROJECT 3 â BIOLOGY OF DNA DEAMINASES IN CANCER$406,749
P01 · FY2025 · CA · contact PI
CORE A - ADMINISTRATIVE CORE$109,321
P01 · FY2025 · CA · contact PI
APOBEC3 Proteins in HIV Restriction$460,050
R37 · FY2024 · AI · contact PI
APOBEC MUTAGENESIS IN BREAST CANCER$1,683,415
P01 · FY2023 · CA · contact PI
APOBEC3 Proteins in HIV Restriction$460,050
R37 · FY2023 · AI · contact PI
PROJECT 1$267,569
P01 · FY2023 · CA · contact PI
PROJECT 1$80,536
P01 · FY2023 · CA · contact PI
APOBEC MUTAGENESIS IN BREAST CANCER$80,536
P01 · FY2023 · CA · contact PI
Midwest AViDD Center$66,431,207
U19 · FY2022 · AI · contact PI
Core A: Administration$7,505,644
U19 · FY2022 · AI · contact PI
Project 3: Pandemic Virus Protease Inhibitors$2,879,997
U19 · FY2022 · AI · contact PI
APOBEC MUTAGENESIS IN BREAST CANCER$1,751,218
P01 · FY2022 · CA · contact PI
Midwest AViDD Center$456,759
U19 · FY2022 · AI · contact PI
APOBEC3 Proteins in HIV Restriction$369,525
R37 · FY2022 · AI · contact PI
PROJECT 1$275,130
P01 · FY2022 · CA · contact PI
APOBEC MUTAGENESIS IN BREAST CANCER$95,930
P01 · FY2022 · CA · contact PI
Administrative-Core-001$95,930
P01 · FY2022 · CA · contact PI
APOBEC3 Proteins in HIV Restriction$90,693
R37 · FY2022 · AI · contact PI
APOBEC MUTAGENESIS IN BREAST CANCER$1,713,487
P01 · FY2021 · CA · contact PI
APOBEC3 Proteins in HIV Restriction$458,762
R37 · FY2021 · AI · contact PI
PROJECT 1$347,814
P01 · FY2021 · CA · contact PI
APOBEC MUTAGENESIS IN BREAST CANCER$1,723,288
P01 · FY2020 · CA · contact PI
Implications and Vulnerabilities of APOBEC Mutagenesis in Breast Cancer$721,982
R01 · FY2020 · CA
APOBEC3 Proteins in HIV Restriction$457,305
R37 · FY2020 · AI · contact PI
PROJECT 1$348,174
P01 · FY2020 · CA · contact PI
APOBEC MUTAGENESIS IN BREAST CANCER$1,656,507
P01 · FY2019 · CA · contact PI
APOBEC3 STRUCTURAL STUDIES$534,174
R01 · FY2019 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$362,712
R37 · FY2019 · AI · contact PI
PROJECT 1$270,112
P01 · FY2019 · CA · contact PI
APOBEC3 STRUCTURAL STUDIES$533,037
R01 · FY2018 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$362,712
R37 · FY2018 · AI · contact PI
APOBEC3 STRUCTURAL STUDIES$35,244
R01 · FY2018 · GM · contact PI
APOBEC3 STRUCTURAL STUDIES$529,626
R01 · FY2017 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$362,712
R37 · FY2017 · AI · contact PI
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS$182,192
R21 · FY2017 · CA · contact PI
2017 RNA Editing Gordon Research Conference and Gordon Research Seminar$3,000
R13 · FY2017 · CA · contact PI
APOBEC3 STRUCTURAL STUDIES$527,352
R01 · FY2016 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$462,062
R37 · FY2016 · AI · contact PI
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS$219,289
R21 · FY2016 · CA · contact PI
APOBEC3 STRUCTURAL STUDIES$79,642
R01 · FY2016 · GM · contact PI
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies$1,971,476
P01 · FY2015 · GM · contact PI
Molecular Biology of APOBECS and Vif Interactions$476,296
P01 · FY2015 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$376,290
R37 · FY2015 · AI · contact PI
MOLECULAR CORE$189,156
P01 · FY2015 · GM · contact PI
ADMINISTRATION CORE$68,983
P01 · FY2015 · GM · contact PI
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies$2,038,887
P01 · FY2014 · GM · contact PI
Molecular Biology of APOBECS and Vif Interactions$490,553
P01 · FY2014 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$363,998
R01 · FY2014 · AI · contact PI
MOLECULAR CORE$194,443
P01 · FY2014 · GM · contact PI
ADMINISTRATION CORE$70,833
P01 · FY2014 · GM · contact PI
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies$1,997,665
P01 · FY2013 · GM · contact PI
Molecular Biology of APOBECS and Vif Interactions$491,355
P01 · FY2013 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$342,158
R01 · FY2013 · AI · contact PI
MOLECULAR CORE$225,649
P01 · FY2013 · GM · contact PI
ADMINISTRATION CORE$79,459
P01 · FY2013 · GM · contact PI
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies$20,263
P01 · FY2013 · GM · contact PI
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies$1,932,999
P01 · FY2012 · GM · contact PI
Molecular Biology of APOBECS and Vif Interactions$504,811
P01 · FY2012 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$363,998
R01 · FY2012 · AI · contact PI
MOLECULAR CORE$212,529
P01 · FY2012 · GM · contact PI
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies$84,141
P01 · FY2012 · GM · contact PI
ADMINISTRATION CORE$77,402
P01 · FY2012 · GM · contact PI
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies$2,098,805
P01 · FY2011 · GM · contact PI
Molecular Biology of APOBECS and Vif Interactions$550,563
P01 · FY2011 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$318,498
R01 · FY2011 · AI · contact PI
MOLECULAR CORE$195,909
P01 · FY2011 · GM · contact PI
ADMINISTRATION CORE$71,765
P01 · FY2011 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$369,881
R56 · FY2010 · AI · contact PI
Mechanisms of AID-dependent Adaptive and Innate Immunity$248,195
R01 · FY2010 · GM · contact PI
APOBEC3 Proteins in HIV Restriction$154,331
R56 · FY2010 · AI · contact PI
Mechanisms of AID-dependent Adaptive and Innate Immunity$52,750
R01 · FY2010 · GM · contact PI
APOBEC3G DNA Deaminase Inhibitor High Throughput Screen$37,373
R03 · FY2010 · MH · contact PI
APOBEC proteins and uracil in retrovirus restriction$307,445
R01 · FY2009 · AI · contact PI
Mechanisms of AID-dependent Adaptive and Innate Immunity$250,771
R01 · FY2009 · GM · contact PI
DNA Repair Defects in IgA Deficiency$185,818
R21 · FY2009 · AI · contact PI
APOBEC proteins and uracil in retrovirus restriction$86,976
R01 · FY2009 · AI · contact PI
APOBEC3G DNA Deaminase Inhibitor High Throughput Screen$37,750
R03 · FY2009 · MH · contact PI
APOBEC proteins and uracil in retrovirus restriction$304,585
R01 · FY2008 · AI · contact PI
Mechanisms of AID-dependent Adaptive and Innate Immunity$250,838
R01 · FY2008 · GM · contact PI
DNA Repair Defects in IgA Deficiency$224,250
R21 · FY2008 · AI · contact PI
APOBEC proteins and uracil in retrovirus restriction$307,655
R01 · FY2007 · AI · contact PI
Mechanisms of AID-dependent Adaptive and Innate Immunity$250,903
R01 · FY2007 · GM · contact PI
APOBEC proteins and uracil in retrovirus restriction$314,014
R01 · FY2006 · AI · contact PI
APOBEC proteins and uracil in retrovirus restriction$270,770
R01 · FY2005 · AI